Global Hereditary Angioedema Treatment Market Industry Analysis, Size, Share, Growth, Trends & Forecast, 2019-2027 - ResearchAndMarkets.com

DUBLIN--()--The "Hereditary Angioedema Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Hereditary Angioedema Treatment Market - Scope of the Report

the report on the global hereditary angioedema treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global hereditary angioedema treatment market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global hereditary angioedema treatment market for the forecast period.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global hereditary angioedema treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global hereditary angioedema treatment market.

The report delves into the competitive landscape of the global hereditary angioedema treatment market. Key players operating in the global hereditary angioedema treatment market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global hereditary angioedema treatment market that have been profiled in this report.

Key Questions Answered in the Hereditary Angioedema Treatment market Report

  • What is the sales/revenue expected to be generated by each drug class and route of administration segment of the hereditary angioedema treatment market across all regions during the forecast period?
  • What are the opportunities in the global hereditary angioedema treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is likely to expand at the fastest CAGR during the forecast period?
  • Which hereditary angioedema drug class, route of administration, and distribution channel segments are expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What was the market share or position of different companies operating in the global market in 2018?

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hereditary Angioedema Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Drug Class Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Hereditary Angioedema Treatment Market Analysis and Forecast, 2017-2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Pipeline Analysis

5.2. Orphan Drug Exclusivity Scenario

5.3. Key Merger & Acquisitions

5.4. Disease Overview

5.5. Disease Prevalence-Global and Key Countries

6. Global Hereditary Angioedema Treatment Market Analysis and Forecast, by Drug Class, 2017-2027

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Drug Class, 2017-2027

6.3.1. C1 Esterase Inhibitor

6.3.2. Selective Bradykinin B2 Receptor Antagonist

6.3.3. Kallikrein Inhibitor

6.3.4. Others

6.4. Market Attractiveness By Drug Class

7. Global Hereditary Angioedema Treatment Market Analysis and Forecasts, by Route of Administration, 2017-2027

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Route of Administration, 2017-2027

7.3.1. Intravenous

7.3.2. Subcutaneous Injection

7.3.3. Oral

7.4. Market Attractiveness, by Route of Administration

8. Global Hereditary Angioedema Treatment Market Analysis and Forecasts, by Distribution Channel, 2017-2027

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Distribution Channel, 2017-2027

8.4. Market Attractiveness, by Distribution Channel

9. Global Hereditary Angioedema Treatment Market Analysis and Forecasts, by Region, 2017-2027

9.1. Key Findings

9.2. Market Value Forecast, by Region

9.3. Market Attractiveness, by Country/Region

10. North America Hereditary Angioedema Treatment Market Analysis and Forecast, 2017-2027

10.1. Introduction

10.2. Market Value Forecast, by Drug Class, 2017-2027

10.3. Market Value Forecast, by Route of Administration, 2017-2027

10.4. Market Value Forecast, by Distribution Channel, 2017-2027

10.5. Market Value Forecast, by Country, 2017-2027

10.6. Market Attractiveness Analysis

11. Europe Hereditary Angioedema Treatment Market Analysis and Forecast, 2017-2027

12. Rest of the World Hereditary Angioedema Treatment Market Analysis and Forecast, 2017-2027

13. Competitive Landscape

13.1. Market Player - Competition Matrix (By Tier and Size of companies)

13.2. Market Share Analysis, by Company, 2018

13.3. Company Profiles

13.3.1. Shire Plc

13.3.2. CSL Limited

13.3.3. Pharming Group N.V.

13.3.4. Ionis Pharmaceuticals, Inc.

13.3.5. BioCryst Pharmaceuticals, Inc.

13.3.6. KalVista Pharmaceuticals Ltd.

13.3.7. Attune Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/g2jrcb

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900